Research has demonstrated that inflammatory cytokines (e.g., IL-6, TNF-α) can inhibit erythrocyte maturation, leading to increased RDW (19), while simultaneously activating oncogenic pathways such as STAT3, promoting tumorigenesis, immune evasion, and driving bladder cancer progression (20). Here, IL6 is linked to urinary bladder cancer.